Pharmaceutical stocks worth investing in

Pharmaceutical stocks worth investing in

Whether pharmaceutical stocks are worth investing needs to consult relevant information to answer. According to years of study experience, if you can get a plan worth investing in pharmaceutical stocks, you can get twice the result with half the effort. Let's share the relevant experience of investing in pharmaceutical stocks for your reference.

Pharmaceutical stocks worth investing in

Investing in pharmaceutical stocks requires careful stock selection, because this industry is characterized by high risk and high return. The following are some pharmaceutical stocks that may be worth investing in:

Hengrui Pharma (600276): This company is a large comprehensive pharmaceutical company, focusing on the research and development of innovative drugs and generic drugs. Hengrui Pharma has a strong R&D strength, and many innovative drugs have entered the clinical trial stage.

Shanghai Pharmaceutical (600607): This company is one of the leading enterprises in the domestic pharmaceutical industry, mainly engaged in pharmaceutical manufacturing and sales. Shanghai Pharmaceutical has a rich product line and extensive sales channels and partners in China market.

Baiyunshan (600332): This company is a large comprehensive pharmaceutical company in China pharmaceutical industry, mainly producing antibiotics, antiviral drugs and cardiovascular drugs. Baiyun Mountain has also made some progress in drug research and development, and has a wide range of sales channels and partners in China market.

It should be noted that investment in pharmaceutical stocks needs to understand relevant industry and market risks, and conduct full due diligence and risk assessment. At the same time, pharmaceutical stocks fluctuate greatly, so investors should do a good job in risk management and control their positions and risks.

Pharmaceutical stocks worth starting with

There are many pharmaceutical stocks. Here are some for you:

1. WuXi PharmaTech: WuXi PharmaTech is a leading pharmaceutical R&D service platform in China, providing pharmaceutical enterprises with all-round integrated pharmaceutical R&D services such as preclinical toxicology, phase I-IV clinical trials, registration and declaration, conformity evaluation, clinical cro, customized R&D and production.

2. Tiger Pharmaceuticals: Tiger Pharmaceuticals is a leading clinical contract research institution in China, which can provide cutting-edge global clinical research services for pharmaceutical products and medical projects.

3.Gloria: Gloria is the world's leading R&D drug outsourcing service provider featuring innovation. At present, the company has the distinct advantage of internationalization, and has invested in several parks in China to build a super-large-scale pharmaceutical clinical trial industrial base.

4. Kanglong Chenghua: Kanglong Chenghua is the world's leading drug research and development service organization, providing full-process services for new drug research and development.

5. Zhao Yan New Drugs: Zhao Yan New Drugs provides services such as non-clinical safety evaluation and preclinical research and development of new drugs. It is one of the earliest preclinical research service providers in China to establish a drug non-clinical safety evaluation center.

The above recommended rankings are in no particular order and are for reference only. You can choose your own pharmaceutical stocks according to your own needs and market changes.

High-end pharmaceutical stocks worth investing in

Investing in high-end pharmaceutical stocks needs to pay attention to the company's R&D ability, product pipeline, sales ability, industry competition pattern, industry development trend and other factors. The following are some high-end pharmaceutical stocks worthy of attention:

_ _ Wuxi PharmaTech (02359): The company is the largest pharmaceutical clinical R&D service outsourcing organization in China, providing integrated and full-process supply chain services for the global biomedical industry.

_ _ Hengrui Pharma (600276): The company is a leading chemical and pharmaceutical enterprise in China, committed to the research and development of innovative drugs and industrial transformation.

_ _ Mindray Medical (300760): The company is a leading supplier of medical devices and solutions, and its product line covers many fields.

_ _ Tiger Medicine (300347): The company is a leading medical technical service and R&D outsourcing company in China, providing clinical trials and related services for the pharmaceutical industry.

_ _ Fan Jian Bio (300529): The company is a leading enterprise in the field of blood purification in China, and its main products include medical devices such as hemoperfusion devices and hemodialysis devices.

The investment value of these stocks depends on their performance, market prospects, industry competition and other factors. Investors need to make comprehensive consideration according to their own risk tolerance, investment purpose and time.

What pharmaceutical stocks are worth investing in abroad?

The following are some foreign pharmaceutical stocks worthy of attention:

_ _ Merck Serono, with a year-on-year growth of 22% in China market in 20021,owns Bering capsules, domicile and other products.

_ _ Thermo Fisher Scientific Shier Technology, 202 1 has a year-on-year increase of 36% in China, and has more than 800 sales engineers and industry experts in China, which can quickly respond to customer needs.

_ _ Roche, 202 1, growing in China 17%, China is Roche's largest market in the world.

_ _ Novartis, 202 1, year-on-year growth in China 14%. An Gaobo, President of Novartis China, said: China is the second largest market of Novartis in the world, next to the United States.

_ _ Bayer, 202 1, year-on-year growth in China 14%. Pan Jinsheng, CEO of Greater China, said: China is Bayer's second largest market in the world.

_ _ GlaxoSmithKline, 202 1, year-on-year growth in China 14%. Zhou Tao, President of China, said: China is the fastest growing market for GlaxoSmithKline and one of the three strategic markets of the Group in the world.

These companies have stable growth and market share and deserve long-term attention and investment. However, the investment market is risky, and investors need to make decisions according to their risk tolerance and investment objectives.

China pharmaceutical stocks worth investing in.

You need to choose carefully when investing in China pharmaceutical stocks. The following are some China pharmaceutical stocks worthy of attention:

1. Baiyun Mountain: Baiyun Mountain is a large pharmaceutical company in China. Its products include antibiotics, antitumor drugs, digestive drugs and respiratory drugs. Baiyun Mountain has a strong R&D strength and a rich product line, and also has a certain expansion in overseas markets.

2. Mindray Medical: Mindray Medical is a leading manufacturer of medical devices in China, and its products cover life information and support, in vitro diagnosis, medical imaging and other fields. In recent years, Mindray Medical has continuously expanded its product line and market share through independent research and development and active acquisition.

3. WuXi PharmaTech: WuXi PharmaTech is one of the largest drug research and development service providers in China, and its business includes drug discovery, drug development and clinical trials. Wuxi pharmatech provides comprehensive drug research and development services through cooperation with leading pharmaceutical companies in the world.

4. Hualan Bio: Hualan Bio is one of the leading blood products companies in China, and its products include human albumin, immunoglobulin and coagulation factors. Hualan Bio has strong R&D strength and market competitiveness, and also has certain expansion space in overseas markets.

Please note that investment is risky, please fully investigate and analyze before investing.

The introduction of pharmaceutical stocks worth investing ends here.